Browsing Medicine Research by Author "GE, Junbo"
Now showing items 1-4 of 4
-
Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
Zhang, Haijun; Wang, Xiangfei; Deng, Wei; Wang, Shenguo; Ge, Junbo; Toft, Egon... more authors ... less authors ( Wolters Kluwer Health, Inc , 2016 , Article)Background: The biodegradable polymer drug-eluting stents (DES) were developed to improve vascular healing. However, further data and longer-term follow-up are needed to confirm safety and efficacy of these stents. This ... -
Research on elastic recoil and restoration of vessel pulsatility of Zn-Cu biodegradable coronary stents
Zhou, Chao; Feng, Xiangyi; Shi, Zhangzhi; Song, Caixia; Cui, Xiaoshan; Zhang, Junwei; Li, Ting; Toft, Egon Steen; GE, Junbo; Wang, Luning; Zhang, Haijun... more authors ... less authors ( De Gruyter , 2020 , Article)Coronary stents made of zinc (Zn)-0.8 copper (Cu) (in wt%) alloy were developed as biodegradable metal stents (Zn-Cu stents) in this study. The mechanical properties of the Zn-Cu stents and the possible gain effects were ... -
Solely abluminal drug release from coronary stents could possibly improve reendothelialization
Zhang, Haijun; Deng, Wei; Wang, Xiangfei; Wang, Shenguo; Ge, Junbo; Toft, Egon... more authors ... less authors ( John Wiley and Sons Inc. , 2016 , Article)Objectives To compare a new stent with an asymmetric coating, eluting the drug to the abluminal surface, to a stent with a conventional coating eluting the drug both to the luminal and the abluminal side. Background Stents ... -
Ultrasound controlled paclitaxel releasing system—A novel method for improving the availability of coronary artery drug coated balloon
Song, Caixia; Zhou, Chao; Zhang, Junwei; Feng, Xiangyi; Cui, Xiaoshan; Zhang, Feng; Ma, Jianying; Toft, Egon Steen; Ge, Junbo; Zhang, Haijun... more authors ... less authors ( Wiley , 2020 , Article)Objectives: The aim of this study is to improve local-drug delivery efficiency and tissue absorption using the ultrasound (US)-responsible drug coating based on a newly developed US-controlled paclitaxel release balloon. ...